nach oben

International Journal of Clinical Oncology

Erschienen in:

01.06.2013 | Original Article

The relationship between urinary bisphenol A levels and meningioma in Chinese adults

verfasst von: Bo Duan, Xuebin Hu, Hongyang Zhao, Jun Qin, Jie Luo

Erschienen in: International Journal of Clinical Oncology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Estrogen has been implicated as a risk factor for meningioma. Bisphenol A (BPA), a widely used synthetic xenoestrogen, has already been reported to be associated with several estrogen-sensitive tumors.

Method

An exploratory association study of 243 meningioma cases and 258 frequency-matched healthy controls was conducted, using subjects from a hospital-based study to demonstrate the association of urine BPA concentration and the risk of meningioma. The specimens and data of patients were collected at Union Hospital, Wuhan, China, from 2009 to 2010.

Results

A positive association between increasing levels of urinary BPA and meningioma was observed, independent of confounding factors such as gender, age, race, body mass index, HRT use, BMI, and family history of cancer. Compared to quartile 1 (referent), the multivariate-adjusted odds ratio of meningioma associated with quartile 4 was 1.45 (95 % CI, 1.02–1.98) (P trend = 0.03).

Conclusion

In this case–control study from China, a clear association between urinary BPA concentrations and diagnosis of meningioma was detected.

Longstreth WT, Dennis LK, McGurire VM et al (1993) Epidemiology of intracranial meningioma. Cancer (Phila) 72:639–648CrossRef

Sadetzki S, Flint-Richter P, Ben-Tal T et al (2002) Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg 97:1078–1082PubMedCrossRef

Alexiou GA, Markoula S, Gogou P et al (2011) Genetic and molecular alterations in meningiomas. Clin Neurol Neurosurg 113:261–267PubMedCrossRef

Whittle IR, Smith C, Navoo P et al (2004) Meningiomas. Lancet 363:1535–1543PubMedCrossRef

Roelvink NC, Kamphorst W, van Alphen HA et al (1987) Pregnancy-related primary brain and spinal tumors. Arch Neurol 44:209–215PubMedCrossRef

Schoenberg BS, Christine BW, Whisnant JP (1975) Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 25:705–712PubMedCrossRef

Carroll RS, Zhang J, Black PM (1999) Expression of estrogen receptors alpha and beta in human meningiomas. J Neurooncol 42:109–116PubMedCrossRef

Hsu DW, Efird JT, Hedley-Whyte ET (1997) Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86:113–120PubMedCrossRef

Speirs V, Boyle-Walsh E, Fraser WD (1997) Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones. Int J Cancer 72:714–719PubMedCrossRef

10.

Michaud DS, Gallo V, Schlehofer B et al (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562–2569PubMedCrossRef

11.

Pines A (2010) Hormone therapy and brain tumors. Climacteric 14:215–216PubMedCrossRef

12.

Blitshteyn S, Crook JE, Jaeckle KA (2008) Is there an association between meningioma and hormone replacement therapy? J Clin Oncol 26:279–282PubMedCrossRef

13.

Claus EB, Black PM, Bondy ML et al (2007) Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer (Phila) 110:471–476CrossRef

14.

Calafat AM, Ye X, Wong LY et al (2008) Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003–2004. Environ Health Perspect 116:39–44PubMedCrossRef

15.

Rubin BS (2011) Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127:27–34PubMedCrossRef

16.

Kundakovic M, Champagne FA (2011) Epigenetic perspective on the developmental effects of bisphenol A. Brain Behav Immun 25:1084–1093PubMedCrossRef

17.

Wolstenholme JT, Rissman EF, Connelly JJ (2010) The role of bisphenol A in shaping the brain, epigenome and behavior. Horm Behav 59:296–305PubMedCrossRef

18.

Okada H, Tokunaga T, Liu X et al (2008) Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ Health Perspect 116:32–38PubMedCrossRef

19.

Matsushima A, Kakuta Y, Teramoto T et al (2007) Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma. J Biochem 142:517–524PubMedCrossRef

20.

Melzer D, Harries L, Cipelli R et al (2011) Bisphenol A exposure is associated with in vivo estrogenic gene expression in adults. Environ Health Perspect 127:27–34

21.

Soto AM, Vandenberg LN, Maffini MV et al (2008) Does breast cancer start in the womb? Basic Clin Pharmacol Toxicol 102:125–133PubMedCrossRef

22.

Henderson BE, Bernstein L, Ross RK et al (1988) The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer 57:216–218PubMedCrossRef

23.

Powell IJ, Meyskens FL (2001) African American men and hereditary/familial prostate cancer: intermediate-risk populations for chemoprevention trials. Urology 57:178–181PubMedCrossRef

24.

Timms BG, Howdeshell KL, Barton L et al (2005) Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA 102:7014–7019PubMedCrossRef

25.

Ho SM, Tang WY, Belmonte de Frausto J et al (2006) Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66:5624–5632PubMedCrossRef

26.

Lang IA, Galloway TS, Scarlett A et al (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303–1310PubMedCrossRef

27.

Gazzeri R, Galarza M, Gazzeri G (2007) Growth of a meningioma in a transsexual patient after estrogen-progestin therapy. N Engl J Med 357:2411–2412PubMedCrossRef

28.

Jay JR, MacLaughlin DT, Riley KP et al (1985) Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 62:757–762PubMedCrossRef

29.

Vandenberg LN, Maffini MV, Sonnenschein C et al (2009) Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 30:75–95PubMedCrossRef

30.

Calafat AM, Kuklenyik Z, Reidy JA et al (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391–395PubMedCrossRef

31.

Hiroi H, Tsutsmi O, Momoeda M et al (1999) Differential interactions of bisphenol A and 17-beta-estradiol with estrogen receptor alpha (ER-alpha) and ER-beta. Endocr J 46:773–778PubMedCrossRef

32.

Matthews JB, Twomey K, Zacharewski TR (2001) In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem Res Toxicol 14:149–157PubMedCrossRef

33.

Lewis JB, Lapp CA, Schafer TE et al (2000) 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines. In Vitro Cell Dev Biol Anim 36:320–326PubMedCrossRef

34.

Lapensee EW, Tuttle TR, Fox SR et al (2009) Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells. Environ Health Perspect 117:175–180PubMed

35.

Rubin BS, Soto AM (2009) Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol 304:55–62PubMedCrossRef

36.

Newbold RR, Padilla-Banks E, Jefferson WN (2009) Environmental estrogens and obesity. Mol Cell Endocrinol 304:84–89PubMedCrossRef

37.

Shankar A, Teppala S (2011) Relationship between urinary bisphenol A levels and diabetes mellitus. J Clin Endocrinol Metab 15:3455–3462

38.

Benson VS, Pirie K, Green J et al (2008) Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 99:185–190PubMedCrossRef

39.

Jhawar BS, Fuchs CS, Colditz GA et al (2003) Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99:848–853PubMedCrossRef

40.

Michaud DS, Bove G, Gallo V et al (2011) Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study. Cancer Prev Res (Phila) 4:1385–1392CrossRef

Titel: The relationship between urinary bisphenol A levels and meningioma in Chinese adults
verfasst von: Bo Duan
Xuebin Hu
Hongyang Zhao
Jun Qin
Jie Luo
Publikationsdatum: 01.06.2013
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 3/2013
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-012-0408-6

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

The relationship between urinary bisphenol A levels and meningioma in Chinese adults

Abstract

Background

Method

Results

Conclusion

Neu im Fachgebiet Onkologie

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Update Onkologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Background

Method

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Attributes of brain metastases from breast and lung cancer

Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma

Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancer

Set-up errors and planning target volume margins in head and neck cancer radiotherapy: a clinical study of image guidance with on-line cone-beam computed tomography

Evolution of the techniques of radiation therapy in the management of lymphoma

A retrospective comparison of S-1 plus cisplatin and capecitabine plus cisplatin for patients with advanced or recurrent gastric cancer

Neu im Fachgebiet Onkologie

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Update Onkologie